Inhibitors of MicroRNA-miR712/miR205 for the Treatment of Atherosclerosis and Other Vascular Conditions
Application
Antisense oligonucleotide inhibitors of microRNA-miR712/miR205 to prevent or treat atherosclerosis and aortic aneurysm.
Key Benefits
80% reduction on the expression of their microRNA targets.
Reduces atheroma plaque formation in a mouse model of atherosclerosis.
Provides potential non-surgical treatment for aortic aneurysm.
Market...
Published: 7/28/2023
Contributor(s): Hanjoong Jo, Chanwoo Kim, Sandeep Kumar, Dong ju Son, Haiwei Qiu, Wakako Takabe
|